Sensient Technologies Corporation (SXT)
NYSE: SXT · Real-Time Price · USD
116.00
-0.62 (-0.53%)
Aug 11, 2025, 4:00 PM - Market closed
Intra-Cellular Therapies Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$110.00
Upside
-5.17%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $93 → $125 | Buy | Maintains | $93 → $125 | +7.76% | Jul 3, 2025 |
| CJS Securities | CJS Securities | Hold Initiates $95 | Hold | Initiates | $95 | -18.10% | Jun 10, 2025 |
| Baird | Baird | Buy Maintains $85 → $93 | Buy | Maintains | $85 → $93 | -19.83% | Apr 28, 2025 |
| Baird | Baird | Buy Maintains $80 → $85 | Buy | Maintains | $80 → $85 | -26.72% | Jul 29, 2024 |
| Baird | Baird | Buy Maintains $70 → $80 | Buy | Maintains | $70 → $80 | -31.03% | Apr 29, 2024 |
| Baird | Baird | Hold → Buy Upgrades $70 | Hold → Buy | Upgrades | $70 | -39.66% | Oct 17, 2023 |
| Baird | Baird | Hold Maintains $90 → $70 | Hold | Maintains | $90 → $70 | -39.66% | Oct 24, 2022 |
| Baird | Baird | Hold Initiates $90 | Hold | Initiates | $90 | -22.41% | May 27, 2021 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $70 | Buy | Initiates | $70 | -39.66% | Jul 10, 2020 |
| Keybanc | Keybanc | Buy → Hold Downgrades $65 | Buy → Hold | Downgrades | $65 | -43.97% | Feb 19, 2019 |
| Keybanc | Keybanc | Buy Maintains $80 → $73 | Buy | Maintains | $80 → $73 | -37.07% | Oct 22, 2018 |
| Berenberg | Berenberg | Strong Buy Initiates $88 | Strong Buy | Initiates | $88 | -23.88% | Sep 22, 2017 |
| Keybanc | Keybanc | Buy Maintains $71 → $66 | Buy | Maintains | $71 → $66 | -43.10% | Feb 9, 2016 |
| Keybanc | Keybanc | Buy Maintains $68 → $73 | Buy | Maintains | $68 → $73 | -37.07% | Apr 14, 2015 |
| Keybanc | Keybanc | Hold → Strong Buy Upgrades $56 | Hold → Strong Buy | Upgrades | $56 | -51.72% | Jan 9, 2014 |